Just noticed something interesting about BTSG in the medical stocks space. This healthcare services company is actually crushing it compared to the broader medical sector this year. While most medical stocks are basically flat or down, BTSG is up 12% year-to-date. That's a pretty solid gap when you look at how the rest of the sector is performing.

The thing that caught my eye is the earnings outlook. Analyst estimates for BTSG's full-year earnings have been revised upward by 8.2% in just the past quarter. That usually means people are getting more bullish on the company's prospects. It's got a strong buy rating too, which aligns with the positive momentum.

There's another medical stock worth watching in this category - CCCC. That one's actually up way more at 61.8% year-to-date, though it's in a different segment of medical stocks (biotech/genetics). Their earnings estimates are also getting upgraded, up 16.8% over three months.

Within the healthcare services subsector specifically, most medical stocks are down about 2.9% so far this year, which makes BTSG's performance even more impressive. If you're looking at medical stocks right now, these are definitely two worth keeping on your radar. The momentum seems to be there for both.